International Clinical Trial: A Randomized, Open-label, Single-dose, Two-sequence, Two-period, Crossover Bioequivalence Study of Trazodone Hydrochloride Extended-Release Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119502) titled 'A Randomized, Open-label, Single-dose, Two-sequence, Two-period, Crossover Bioequivalence Study of Trazodone Hydrochloride Extended-Release Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions' on Feb. 28.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: The Second Affiliated Hospital Of Xingtai Medical College

Condition: Depression

Intervention: TR Sequence Group in the Fed Study:In the first cycle, take the test formulation T (1 tablet) after meals in the second cycle, take the reference formulation R (1 tablet) on an empty stomach or after meals washout period ...